Dr. Martens plc (LON:DOCS – Get Free Report) shares shot up 2.1% during trading on Wednesday . The stock traded as high as GBX 75.80 ($0.96) and last traded at GBX 73.80 ($0.93). 750,729 shares changed hands during mid-day trading, a decline of 56% from the average session volume of 1,721,581 shares. The stock had previously closed at GBX 72.25 ($0.91).
Dr. Martens Trading Up 2.1 %
The company’s 50-day moving average is GBX 80.89 and its 200-day moving average is GBX 84.98. The company has a debt-to-equity ratio of 143.48, a quick ratio of 1.13 and a current ratio of 2.44. The firm has a market cap of £709.91 million, a price-to-earnings ratio of 738.00, a P/E/G ratio of 0.04 and a beta of 0.01.
Dr. Martens Cuts Dividend
The company also recently announced a dividend, which will be paid on Tuesday, October 1st. Stockholders of record on Thursday, August 29th will be given a dividend of GBX 0.99 ($0.01) per share. The ex-dividend date is Thursday, August 29th. This represents a dividend yield of 1.18%. Dr. Martens’s payout ratio is currently 6,000.00%.
Insider Buying and Selling
Dr. Martens Company Profile
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
See Also
- Five stocks we like better than Dr. Martens
- How to Read Stock Charts for Beginners
- AbbVie Stock: A Perfect Dip for Investors to Buy
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.